The University of Chicago Header Logo

Connection

Daniel Shevrin to Hematologic Diseases

Back to Details
This is a "connection" page, showing publications Daniel Shevrin has written about Hematologic Diseases.
Daniel Shevrin
Connection Strength
0.011
Hematologic Diseases
  1. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). Am J Clin Oncol. 2000 Aug; 23(4):371-5.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.